Latest Insider Transactions at Repligen Corp (RGEN)
This section provides a real-time view of insider transactions for Repligen Corp (RGEN). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of REPLIGEN CORP to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of REPLIGEN CORP's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 16
2024
|
Margaret Pax |
BUY
Grant, award, or other acquisition
|
Direct |
701
+46.92%
|
-
|
|
May 16
2024
|
Rohin Mhatre |
BUY
Grant, award, or other acquisition
|
Direct |
701
+18.71%
|
-
|
|
May 16
2024
|
Konstantin Konstantinov |
BUY
Grant, award, or other acquisition
|
Direct |
701
+26.74%
|
-
|
|
May 16
2024
|
Karen A Dawes |
BUY
Grant, award, or other acquisition
|
Direct |
803
+0.9%
|
-
|
|
May 16
2024
|
Nicolas Barthelemy |
BUY
Grant, award, or other acquisition
|
Direct |
701
+16.81%
|
-
|
|
May 16
2024
|
Manner Carrie Eglinton |
BUY
Grant, award, or other acquisition
|
Direct |
701
+16.71%
|
-
|
|
May 16
2024
|
Glenn P Muir |
BUY
Grant, award, or other acquisition
|
Direct |
701
+7.8%
|
-
|
|
May 14
2024
|
Ralf Kuriyel Senior VP, R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
534
-2.2%
|
$87,042
$163.34 P/Share
|
|
May 14
2024
|
Christine Gebski |
SELL
Payment of exercise price or tax liability
|
Direct |
334
-1.2%
|
$54,442
$163.34 P/Share
|
|
Apr 02
2024
|
James Bylund Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
444
-2.11%
|
$80,808
$182.95 P/Share
|
|
Mar 18
2024
|
Anthony Hunt |
SELL
Bona fide gift
|
Direct |
2,000
-1.08%
|
-
|
|
Mar 18
2024
|
Margaret Pax |
BUY
Grant, award, or other acquisition
|
Direct |
92
+50.0%
|
-
|
|
Mar 11
2024
|
Ralf Kuriyel Senior VP, R&D |
SELL
Open market or private sale
|
Direct |
3,517
-12.66%
|
$678,781
$193.73 P/Share
|
|
Mar 11
2024
|
Ralf Kuriyel Senior VP, R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
1,271
+4.38%
|
$109,306
$86.1 P/Share
|
|
Mar 08
2024
|
Anthony Hunt |
SELL
Open market or private sale
|
Direct |
16,707
-1.07%
|
$3,324,693
$199.02 P/Share
|
|
Mar 08
2024
|
Anthony Hunt |
BUY
Exercise of conversion of derivative security
|
Direct |
1
+0.0%
|
$16
$16.55 P/Share
|
|
Mar 07
2024
|
Ralf Kuriyel Senior VP, R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
386
-1.44%
|
$75,270
$195.72 P/Share
|
|
Mar 07
2024
|
Anthony Hunt |
SELL
Payment of exercise price or tax liability
|
Direct |
2,867
-1.4%
|
$559,065
$195.72 P/Share
|
|
Mar 07
2024
|
Christine Gebski |
SELL
Payment of exercise price or tax liability
|
Direct |
386
-1.37%
|
$75,270
$195.72 P/Share
|
|
Mar 07
2024
|
James Bylund Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,206
-5.42%
|
$235,170
$195.72 P/Share
|
|
Mar 05
2024
|
Anthony Hunt |
SELL
Payment of exercise price or tax liability
|
Direct |
7,275
-3.43%
|
$1,418,625
$195.52 P/Share
|
|
Mar 05
2024
|
James Bylund Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
22
-0.1%
|
$4,290
$195.52 P/Share
|
|
Mar 04
2024
|
Anthony Hunt |
SELL
Payment of exercise price or tax liability
|
Direct |
1,111
-0.52%
|
$214,423
$193.99 P/Share
|
|
Mar 04
2024
|
James Bylund Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
197
-0.88%
|
$38,021
$193.99 P/Share
|
|
Mar 04
2024
|
Christine Gebski |
SELL
Payment of exercise price or tax liability
|
Direct |
592
-1.03%
|
$114,256
$193.35 P/Share
|
|
Mar 04
2024
|
Ralf Kuriyel Senior VP, R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
135
-0.5%
|
$26,055
$193.99 P/Share
|
|
Mar 01
2024
|
James Bylund Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
50
+0.22%
|
-
|
|
Mar 01
2024
|
Ralf Kuriyel Senior VP, R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
453
-1.65%
|
$86,523
$191.79 P/Share
|
|
Mar 01
2024
|
James Bylund Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
820
-3.53%
|
$156,620
$191.79 P/Share
|
|
Mar 01
2024
|
Christine Gebski |
SELL
Payment of exercise price or tax liability
|
Direct |
447
-1.53%
|
$85,377
$191.79 P/Share
|
|
Mar 01
2024
|
Anthony Hunt |
SELL
Payment of exercise price or tax liability
|
Direct |
3,322
-1.53%
|
$634,502
$191.79 P/Share
|
|
Feb 29
2024
|
Ralf Kuriyel Senior VP, R&D |
BUY
Grant, award, or other acquisition
|
Direct |
404
+1.45%
|
-
|
|
Feb 29
2024
|
James Bylund Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
404
+1.71%
|
-
|
|
Feb 29
2024
|
Christine Gebski |
BUY
Grant, award, or other acquisition
|
Direct |
391
+1.32%
|
-
|
|
Feb 29
2024
|
Anthony Hunt |
BUY
Grant, award, or other acquisition
|
Direct |
2,504
+1.14%
|
-
|
|
Feb 27
2024
|
James Bylund Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,691
+27.58%
|
-
|
|
Feb 27
2024
|
Anthony Hunt |
BUY
Grant, award, or other acquisition
|
Direct |
19,719
+8.44%
|
-
|
|
Feb 27
2024
|
Ralf Kuriyel Senior VP, R&D |
BUY
Grant, award, or other acquisition
|
Direct |
3,520
+11.5%
|
-
|
|
Feb 27
2024
|
Jason K Garland CFO |
BUY
Grant, award, or other acquisition
|
Direct |
2,540
+24.0%
|
-
|
|
Feb 27
2024
|
Olivier Loeillot Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,880
+15.43%
|
-
|
|
Feb 27
2024
|
Karen A Dawes |
SELL
Open market or private sale
|
Direct |
1,000
-1.13%
|
$193,000
$193.35 P/Share
|
|
Feb 27
2024
|
Karen A Dawes |
BUY
Exercise of conversion of derivative security
|
Direct |
4,626
+4.97%
|
$194,292
$42.07 P/Share
|
|
Feb 23
2024
|
James Bylund Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
4,373
-23.63%
|
$865,854
$198.08 P/Share
|
|
Feb 23
2024
|
James Bylund Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
940
+4.83%
|
$88,360
$94.33 P/Share
|
|
Nov 14
2023
|
Anthony Hunt |
SELL
Bona fide gift
|
Direct |
1,000
-0.51%
|
-
|
|
Nov 10
2023
|
Christine Gebski |
SELL
Open market or private sale
|
Direct |
3,788
-11.63%
|
$556,836
$147.13 P/Share
|
|
Oct 02
2023
|
Olivier Loeillot Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,906
+50.0%
|
-
|
|
Sep 25
2023
|
Jason K Garland CFO |
BUY
Grant, award, or other acquisition
|
Direct |
5,503
+50.0%
|
-
|
|
Aug 29
2023
|
Karen A Dawes |
SELL
Open market or private sale
|
Direct |
850
-1.0%
|
$145,350
$171.38 P/Share
|
|
Aug 29
2023
|
Karen A Dawes |
BUY
Exercise of conversion of derivative security
|
Direct |
7,392
+8.04%
|
$133,056
$18.12 P/Share
|